OPINION The upcoming HMA-EMA meeting focused on AI presents a pivotal opportunity for healthcare stakeholders to come together and deliberate on the integration of artificial intelligence in medicine. As we…
OPINION The upcoming meeting of the industry stakeholder platform at the European Medicines Agency brings to light a crucial aspect of the pharmaceutical landscape: transparency in regulatory processes. As stakeholders…
OPINION The upcoming EMA/HMA multi-stakeholder forum on EudraVigilance and signal detection symbolizes a pivotal moment in the landscape of pharmacovigilance. As the complexities of drug safety monitoring continue to evolve,…
OPINION The upcoming workshop between notified bodies and expert panels is a crucial step in enhancing regulatory practices within the medical device sector. These collaborative engagements are essential for fostering…
OPINION The upcoming 20th industry stakeholder platform on the operation of EU pharmacovigilance marks a critical juncture for how safety monitoring of medicinal products is approached in the digital age.…
OPINION The upcoming SPOR and XEVMPD status update webinar is an essential event for stakeholders in the pharmaceutical and healthcare industries. It represents a critical opportunity for professionals to stay…
OPINION The upcoming Q&A clinic organized by the European Medicines Agency (EMA) on Substance, Organisation, and Referentials Management Services represents a pivotal opportunity for stakeholders in the pharmaceutical and regulatory…
OPINION The upcoming meeting of the Committee for Medicinal Products for Veterinary Use (CVMP) presents a pivotal opportunity for stakeholders in the veterinary sector to align on critical regulatory frameworks…
OPINION The upcoming Q&A clinic on the eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service is indicative of the growing need for comprehensive understanding in the realm of medicinal regulations. As…